NCT06589440: Phase 2 Study of SR-8541A in Combination with Botensilimab and Balstilimab in Subjects with Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC) |
|
|
| Recruiting | 2 | 70 | US | SR-8541A, Botensilimab, Balstilimab | Stingray Therapeutics | Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC) | 09/27 | 09/27 | | |
DELTACEL-01, NCT06069570: Safety Study for a Gamma Delta T Cell Product Used With Low Dose Radiotherapy in Patients With Stage 4 Metastatic NSCLC |
|
|
| Recruiting | 1 | 48 | US | KB-GDT-01, Low dose radiotherapy | Kiromic BioPharma Inc., Stiris Research Inc, Statistics & Data Corporation | Carcinoma, Non-Small-Cell Lung Cancer | 10/24 | 01/27 | | |
